Filter
301
Text search:
substandard
medicines
Featured
Recommendations
23
New Publications
100
Language
Document type
No document type
152
Studies & Reports
63
Guidelines
33
Strategic & Response Plan
20
Manuals
16
Training Material
6
Fact sheets
5
Situation Updates
4
Infographics
2
Countries / Regions
Kenya
13
Global
13
Western and Central Europe
10
Ethiopia
9
Uganda
9
Malawi
9
Nigeria
8
India
8
Tanzania
7
Africa
7
Sierra Leone
6
Rwanda
6
Liberia
5
Zambia
5
Myanmar / Burma
5
South–East Asia Region
5
Ghana
4
Nepal
4
Syria
4
Cambodia
4
Bangladesh
4
Eswatini/ Swaziland
4
Congo, Democratic Republic of
3
Zimbabwe
3
Namibia
3
Latin America and the Carribbean
3
Cameroon
2
Haiti
2
Philippines
2
Pakistan
2
Thailand
2
South Africa
2
Mozambique
2
Lesotho
2
Asia
2
Vietnam
2
Guinea
1
Jordan
1
Lebanon
1
Indonesia
1
Sudan
1
Central African Republic
1
North Macedonia
1
Ukraine
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Poland
1
Palestine
1
Laos
1
Canada
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
115
Public Health
16
Clinical Guidelines
16
Pharmacy & Technologies
12
Key Resources
10
Capacity Building
3
Women & Child Health
3
Annual Report MEDBOX
1
Toolboxes
AMR
51
Pharmacy
31
TB
26
Malaria
19
HIV
13
COVID-19
10
Global Health Education
7
Conflict
6
NTDs
6
Planetary Health
5
Ebola & Marburg
4
Rapid Response
4
Refugee
4
Mental Health
4
Disability
2
Polio
2
Specific Hazards
1
Caregiver
1
Health Financing Toolbox
1
2.0 Rapid Response
1
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide f
...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Annex 5, WHO Technical Report Series 1010, 2018
Two test methods on dexamethasone tablets and injections
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
100 test methods for 100 active pharmaceutical ingredients
For existing Minilab projects that want to replace old manuals or initiatives that want to start new projects, the new "Minilab Edition 2020" can be obtained at the preferential price of 50 € from our logistic partner Technologie Transfer
...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
This document by Medicines for Malaria Venture (MMV) highlights the significant burden of malaria on children worldwide, emphasizing the need for effective prevention, diagnosis, and treatment strategies. It reviews current challenges and progress i
...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while f
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging partic
...
